YOQNEAM, ISRAEL--(Marketwire)- Given Imaging Ltd., a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that the Intellectual Property Tribunal of the Korean Intellectual Property Office (KIPO) ruled last week that Given Imaging's two Korean patents asserted against Intromedic Co. Ltd. in Seoul's Central District Court are valid.
Given Imaging had filed a patent infringement lawsuit against Intromedic in Seoul's Central District Court in November 2011, asserting that Intromedic's capsule endoscope, marketed under the brand name MiroCam, infringes two Korean patents of Given Imaging. In response, Intromedic commenced proceedings before the KIPO to invalidate the two patents asserted by Given Imaging. The newly-issued decisions by the KIPO reject Intromedic's invalidity arguments and severely cripple one of Intromedic's main defenses against Given Imaging's patent infringement action. These decisions may be appealed by Intromedic.
Given Imaging intends to resume the infringement proceedings that have been stayed pending a resolution in the invalidity proceedings before the KIPO. If the patents are found by Seoul's Central District Court to be infringed by the MiroCam capsule and Given Imaging's request for an injunction is granted, Intromedic, based in Korea, will not be able to manufacture its capsule endoscope in Korea or sell it from Korea to customers worldwide. Rulings in these proceedings are expected by the end of this year.
"We are very pleased with the recent rulings by the Korean Intellectual Property Office. Given Imaging's innovative, state-of-the-art capsule endoscopy products have added a new dimension to GI diagnosis. We have invested considerable intellectual and monetary resources to bring this technology to the world and are determined to use our intellectual property, including approximately 320 registered patents worldwide, to protect our innovative product portfolio," said Homi Shamir, president and CEO, Given Imaging.
About Given Imaging Ltd.
Since pioneering the field of capsule endoscopy in 2001, Given Imaging has become a world leader in GI medical devices, offering health care providers a range of innovative options for visualizing, diagnosing and monitoring the digestive system. The company offers a broad product portfolio including PillCam® video capsules for the small bowel, esophagus and colon [PillCam® COLON not approved for use in the United States.], industry-leading ManoScan™ high-resolution manometry and Bravo® wireless and Digitrapper® pH and impedance products. Given Imaging is committed to delivering breakthrough innovations to the GI community and supporting its ongoing clinical needs. Given Imaging's headquarters are located in Yoqneam, Israel, with operating subsidiaries in the United States, Brazil, Germany, France, Japan, Australia, Vietnam and Hong Kong. For more information, please visit www.givenimaging.com .
Given Imaging Ltd., a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that the Intellectual Property Tribunal of the Korean Intellectual Property Office (KIPO) ruled last week that Given Imaging's two Korean patents asserted against Intromedic Co. Ltd. in Seoul's Central District Court are valid.